{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:16:22Z","timestamp":1785370582600,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.intimp.2020.107038","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T06:04:58Z","timestamp":1609394698000},"page":"107038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study"],"prefix":"10.1016","volume":"91","author":[{"given":"Takahisa","family":"Hiramitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Tomosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morikuni","family":"Nishihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ichimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Narumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuharu","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2020.107038_b0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2020.107038_b0010","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000003192","article-title":"Assessing the complex causes of kidney allograft loss","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"issue":"24","key":"10.1016\/j.intimp.2020.107038_b0015","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.107038_b0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.04050907","article-title":"Recurrent glomerulonephritis after renal transplantation: an unsolved problem","volume":"3","author":"Golgert","year":"2008","journal-title":"CJASN"},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2020.107038_b0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MNH.0b013e32833d6904","article-title":"Recurrent glomerular disease after kidney transplantation","volume":"19","author":"Fairhead","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"4","key":"10.1016\/j.intimp.2020.107038_b0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/TP.0000000000000183","article-title":"The histology of kidney transplant failure: a long-term follow-up study","volume":"98","author":"Naesens","year":"2014","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.intimp.2020.107038_b0040","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/01.ASN.0000023435.07320.81","article-title":"Clinical course of polyoma virus nephropathy in 67 renal transplant patients","volume":"13","author":"Ramos","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107038_b0045","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus De Novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"JASN"},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.smim.2011.09.002","article-title":"Chronic alloantibody mediated rejection","volume":"24","author":"Smith","year":"2012","journal-title":"Sem. Immunol."},{"key":"10.1016\/j.intimp.2020.107038_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation","volume":"2017","author":"Sethi","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107038_b0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1526924816640678","article-title":"Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants","volume":"26","author":"Sharma","year":"2016","journal-title":"Prog Transpl"},{"issue":"12","key":"10.1016\/j.intimp.2020.107038_b0070","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"JASN"},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0075","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2020.107038_b0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2020.107038_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-493-7_2","article-title":"Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury","volume":"1034","author":"Valenzuela","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107038_b0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1681\/ASN.2014040326","article-title":"Non-complement\u2013binding De Novo donor-specific anti-HLA antibodies and kidney allograft survival","volume":"27","author":"Guidicelli","year":"2016","journal-title":"JASN"},{"issue":"5","key":"10.1016\/j.intimp.2020.107038_b0100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.intimp.2020.107038_b0105","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/TP.0000000000001012","article-title":"De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury","volume":"100","author":"Yamamoto","year":"2016","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.intimp.2020.107038_b0110","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development","volume":"28","author":"Wiebe","year":"2017","journal-title":"JASN"},{"issue":"1","key":"10.1016\/j.intimp.2020.107038_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dmpk.2019.10.004","article-title":"The association between trough blood concentration and systemic exposure of tacrolimus: comparison between once-daily (Advagraf\u00ae) and twice-daily (Prograf\u00ae) formulation in de novo kidney transplant recipients","volume":"35","author":"Sukkha","year":"2020","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.intimp.2020.107038_b0120","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/TP.0000000000002566","article-title":"Subclinical antibody-mediated rejection after kidney transplantation: treatment outcomes","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2020.107038_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: new approaches in prevention and management","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2020.107038_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1014-2","article-title":"Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014","volume":"19","author":"Girerd","year":"2018","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2020.107038_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients","volume":"100","author":"O\u2019Leary","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.intimp.2020.107038_b0140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2020.107038_b0145","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/01.TP.0000441097.30094.31","article-title":"Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients","volume":"97","author":"Frassetto","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.intimp.2020.107038_b0150","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1248\/bpb.31.90","volume":"31","author":"Takeuchi","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"38","key":"10.1016\/j.intimp.2020.107038_b0155","doi-asserted-by":"crossref","first-page":"e17312","DOI":"10.1097\/MD.0000000000017312","article-title":"Risk factors and etiology of repeat infection in kidney transplant recipients","volume":"98","author":"Chen","year":"2019","journal-title":"Med. (Baltim.)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692032511X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692032511X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:23:40Z","timestamp":1761585820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692032511X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"alternative-id":["S156757692032511X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107038","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107038"}}